HDAC inhibition: A novel therapeutic target for attenuating myocardial ischemia and reperfusion injury by reversing cardiac remodeling.
Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Jiefang Road 238, Wuchang, 430060 Wuhan, PR China.
Jichun
J
Wang
Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Jiefang Road 238, Wuchang, 430060 Wuhan, PR China.
Xiaorong
X
Hu
Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Jiefang Road 238, Wuchang, 430060 Wuhan, PR China. Electronic address: jianghongwhu@163.com.
Hong
H
Jiang
D016503:Drug Delivery Systems / Q000639:trends; D056572:Histone Deacetylase Inhibitors / Q000008:administration & dosage*; D006801:Humans; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000517:prevention & control*; D015428:Myocardial Reperfusion Injury / Q000175:diagnosis / Q000517:prevention & control*; D020257:Ventricular Remodeling / Q000187:drug effects*
D056572:Histone Deacetylase Inhibitors
Cardiac remodeling; Histone deacetylases (HDACs); Myocardial ischemia and reperfusion injury